Jump Financial, LLC Lyra Therapeutics, Inc. Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$4.55 - $6.53 $15,697 - $22,528
3,450 Added 20.61%
20,187 $125,000
Q4 2023

Oct 21, 2024
BUY
$2.82 - $5.24 $47,198 - $87,701
16,737 New
16,737 $87,000
Q4 2023

Feb 07, 2024
BUY
$2.82 - $5.24 $47,198 - $87,701
16,737 New
16,737 $87,000

Others Institutions Holding LYRA

# of Institutions
62
Shares Held
32.2M
Call Options Held
21.1K
Put Options Held
400
View Full List

About Lyra Therapeutics, Inc.

LYRA Quotes by TradingView
  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $5.73M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email